A detailed history of Private Wealth Management Group, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Private Wealth Management Group, LLC holds 23 shares of PCRX stock, worth $407. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23
Previous 140 83.57%
Holding current value
$407
Previous $4.01 Million 91.34%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$11.7 - $28.46 $1,368 - $3,329
-117 Reduced 83.57%
23 $347,000
Q2 2024

Aug 13, 2024

BUY
$25.5 - $31.51 $3,136 - $3,875
123 Added 723.53%
140 $4.01 Million
Q1 2024

Apr 30, 2024

BUY
$27.7 - $35.48 $470 - $603
17 New
17 $497,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $811M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Private Wealth Management Group, LLC Portfolio

Follow Private Wealth Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Wealth Management Group, LLC with notifications on news.